Related Experiment Video
Updated: Jul 15, 2026
06:16
High Throughput Screening of Fungal Endoglucanase Activity in Escherichia coli
Published on: August 13, 2011
20.6K
Recent Advances in β-Glucosidase Sequence and Structure Engineering: A Brief Review
Bei Ouyang1, Guoping Wang1, Nian Zhang1
1College of Life Science, Jiangxi Normal University, Nanchang 330022, China.
Molecules (Basel, Switzerland)
|July 14, 2023
Summary
Engineering beta-glucosidases (BGLs) enhances their industrial utility by overcoming limitations like low activity and stability. This review details recent advancements in BGL engineering strategies for improved enzyme performance.
Area of Science:
- Biochemistry and Biotechnology
- Enzyme Engineering
- Industrial Microbiology
Background:
- Beta-glucosidases (BGLs) are key enzymes for lignocellulosic biomass breakdown.
- Industrial applications of BGLs are limited by poor enzyme activity, stability, and product inhibition.
- Enzyme engineering offers solutions to enhance BGL characteristics for industrial viability.
Purpose of the Study:
- To review recent advances in beta-glucosidase (BGL) engineering.
- To summarize and discuss strategies used to improve BGLs for industrial applications.
- To highlight efforts from the authors' laboratory in BGL engineering.
Main Methods:
- Literature review of BGL engineering studies.
- Categorization of engineering approaches by targeted function.
- Analysis of specific strategies employed for BGL improvement.
Main Results:
- Identified various engineering strategies to enhance BGLs.
- Discussed methods to overcome limitations such as low activity and product inhibition.
- Highlighted successful BGL engineering efforts.
Conclusions:
- Enzyme engineering is crucial for optimizing BGLs for industrial processes.
- Targeted engineering strategies can significantly improve BGL performance.
- Continued research in BGL engineering will unlock broader industrial applications.
More Related Videos
Related Concept Videos
01:29Protein Folding Quality Check in the RER
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
01:20The Central Dogma
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
01:25Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
01:24Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
01:22Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...